Latest Dilution News

Entropy Neurodynamics has reported encouraging early clinical outcomes from its pioneering intravenous psilocin therapy for Binge Eating Disorder, alongside a patent grant that strengthens its intellectual property moat.

Australis Oil & Gas has partnered with a major US-listed company to develop its Tuscaloosa Marine Shale assets, retaining a 10% interest in producing wells and holding a strong cash position after recent transactions.

Cambium Bio has clinched FDA agreement on a streamlined single pivotal Phase 3 trial for Elate Ocular®, cutting development complexity, while bolstering its cash position through a A$2.4 million strategic placement by major shareholder ZYBT.

Australian Mines Limited's latest scoping study for its Flemington Scandium Project reveals strong financial metrics and significant upside potential tied to scandium pricing, underscoring the project's strategic position in critical minerals.

King River Resources Ltd (ASX: KRR) has completed its acquisition of the Mindoolah Gold Project in Western Australia’s Murchison Province, unveiling a sophisticated exploration program leveraging digital twin technology and high-resolution geophysics to target substantial unmined high-grade gold mineralisation.

Bayan Mining and Minerals delivers strong rare earth assay results from its Desert Star project, advances permitting and drill planning at Bayan Springs South, and strengthens its leadership and strategic positioning.

Raiden Resources is pushing forward with its Crixás Gold Tailings Project in Brazil, planning a 1,000m drilling program to establish a JORC Mineral Resource Estimate and aiming for a Final Investment Decision with less than A$1 million in preliminary costs. Meanwhile, exploration at its Vuzel Gold Project in Bulgaria progresses with permitting for a silver anomaly drill program.

Atomos has finalized its acquisition of Flanders Scientific for $2.35 million cash plus shares, funded by a new $10 million finance facility from Commonwealth Bank. The deal broadens Atomos’ professional video monitoring reach and is expected to add $1 million EBITDA before growth.

Island Pharmaceuticals has cleared a major regulatory hurdle with the US FDA, confirming a clinical development path for its antiviral Galidesivir under the Animal Rule. Backed by a $9 million capital raise and strategic partnerships, the company is poised for potential US government procurement and biodefence market entry.

Infinity Mining has inked a binding farm-in and joint venture deal with Mining One to fund exploration and drilling at its Victorian gold-antimony projects, unlocking a fully financed pathway to test high-priority targets.

NEXTDC has launched the retail tranche of its A$1.5 billion fully underwritten entitlement offer at A$12.70 per share, aiming to back accelerated data centre capacity growth amid unprecedented contracted utilisation.

NT Minerals Limited aims to raise up to $968,722 through a pro-rata entitlement offer and complete the acquisition of Slipstream Paynes Find, a move critical to meeting ASX reinstatement conditions and funding exploration in Western Australia.